Short Interest in Mackenzie Realty Capital, Inc. (NASDAQ:MKZR) Increases By 179.1%

Short interest in Mackenzie Realty Capital (NASDAQ:MKZR) rose 179.1% to 22,394 shares as of May 15, from 8,024 on April 30; days to cover is 0.8 based on average volume, with 1.1% of shares shorted. Weiss Ratings reiterated a “sell (e+)” stance. MKZR reported Q1 EPS of -$0.98 on $6.13M revenue.

Original reporting
Published Jun 1, 2026, 4:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 4:47 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Short Interest in Mackenzie Realty Capital, Inc. (NASDAQ:MKZR) Increases By 179.1% — source image
Decision brief

The 30-second read

$MKZRBearishMed
01

Why it matters

The key tradable signal is the sharp increase in short interest, which can affect borrow demand, volatility, and the probability of short-covering rallies.

02

Market read

Short interest rose sharply in May, providing a near-term positioning/risk catalyst even without a new fundamental event.

03

What to watch

The article also cites weak profitability (negative EPS, margin, ROE) and a CEO insider buy; those fundamentals could dominate price action versus short-interest alone.

Relevance 7/10Novelty 6/10Timing: Ahead of/into the next trading sessions after the May 15 short-interest snapshot.

Background

The article summarizes May short-interest data for Mackenzie Realty Capital (MKZR) and reiterates a sell rating plus recent earnings and insider/institutional activity.

Company-level read

Ticker impact

$MKZRBearishMedium confidence
Context

Article reports MKZR short interest jumped 179.1% in May, with days-to-cover at 0.8 and 1.1% of shares shorted.

Expected impact

Potential for sharp intraday swings; upside squeeze possible if selling pressure unwinds.

Evidence & confidence

The piece provides a fresh, quantified change in short positioning (May 15 vs April 30) plus days-to-cover, which are directly tradable for risk management.

Market effects

Limited direct read-across; short-interest dynamics are company-specific rather than sector-wide in this article.

None indicated; MKZR is a US-listed micro-cap with no regional spillover described.

None indicated; no cross-border deal, funding, or regulatory catalyst mentioned.

Counterpoint

Low days-to-cover (0.8) suggests shorts may be able to exit quickly, so the move could reflect hedging/positioning rather than a sustained bearish thesis.

Key entities

  • Mackenzie Realty Capital, Inc.

    NASDAQ-listed real estate finance firm; subject of the short-interest increase and recent earnings/insider activity mentioned.

  • Weiss Ratings

    Restated a sell rating (e+) on MKZR in an April 8 report, cited as additional sentiment context.

  • Robert E. Dixon

    CEO disclosed a 10,000-share purchase at $3.50 per share on April 6.

Related articles

$SMCIMed

Super Micro Computer Landed $60 Billion in Orders Last Quarter, but Trades at Just $30

Super Micro Computer (SMCI) said it booked over $60B in new orders in its fiscal Q4 ended June 30, lifting backlog to a record. It guided FY2026 revenue near the low end of $11B to $12.5B and gross margins at 15% to 17%. The company also plans $7B equity financing for AI server orders, noting some orders may not be firm and citing an independent review tied to export control issues.

$CSCOMed

Cisco Stock Is Finally Pricing In A New Growth Story

Cisco raised full-year revenue and EPS guidance on May 13, 2026, citing AI infrastructure demand. Management expects about $9 billion in FY2026 AI orders from hyperscalers and cited 5 hyperscaler design wins in Q3. Cisco shares rose about 20% since, with product orders up 19% YoY excluding hyperscaler growth. Options imply 41% IV ahead of the next catalyst.

$RMDMed

Off Into Weekend, As Early Work Undone

ResMed (ASX:RMD) fell 8.29% on Friday and is 3.09% lower for the week after a strong run. The company reported a solid Q4, with FY26 revenue up 10% to $5.7b, gross Q4 margin 62.3%, FY EPS up 17% to $11.17, and a 10% dividend increase to $0.66. Morgan Stanley downgraded to Equal Weight and cut its price target, citing cooling growth and Philips’ potential US return in 2027.